1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TSHZ1 CTRPv2 pan-cancer AAC 0.17 9e-08
mRNA RARS CTRPv2 pan-cancer AAC -0.18 9e-08
mRNA LUC7L CTRPv2 pan-cancer AAC 0.19 9e-08
mRNA CDK19 CTRPv2 pan-cancer AAC 0.18 9e-08
mRNA ZNF417 CTRPv2 pan-cancer AAC 0.17 9e-08
mRNA THEM4 CTRPv2 pan-cancer AAC -0.19 9e-08
mRNA ACTL6B CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA CIC CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA RBBP4 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA MTURN CTRPv2 pan-cancer AAC 0.17 1e-07
Download CSV